13F HOLDINGS REPORT
Octagon Capital Advisors LP
Quarter ended Q2 2023 · Filed May 15, 2023 · Accession 0001214659-23-007162
Total Value
$695.0M
Positions
36
Other Managers
0
Confidential Omitted
No
Holdings (36)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | APELLIS PHARMACEUTICALS INC | APLS | 3,250,000 | $214.4M | 30.84% |
| 2 | CHINOOK THERAPEUTICS INC | 16961L106 | 2,551,703 | $59.1M | 8.50% |
| 3 | VERONA PHARMA PLC | 925050106 | 2,468,000 | $49.6M | 7.13% |
| 4 | CYMABAY THERAPEUTICS INC | 23257D103 | 4,570,918 | $39.9M | 5.73% |
| 5 | ARCUS BIOSCIENCES INC | RCUS | 2,172,000 | $39.6M | 5.70% |
| 6 | VIRIDIAN THERAPEUTICS INC | VRDN | 1,185,000 | $30.1M | 4.34% |
| 7 | ROIVANT SCIENCES LTD | ROIV | 3,904,000 | $28.8M | 4.15% |
| 8 | MIRATI THERAPEUTICS INC | 60468T105 | 750,000 | $27.9M | 4.01% |
| 9 | CELLDEX THERAPEUTICS INC NEW | CLDX | 759,898 | $27.3M | 3.93% |
| 10 | BRIDGEBIO PHARMA INC | BBIO | 1,338,160 | $22.2M | 3.19% |
| 11 | TANDEM DIABETES CARE INC | TNDM | 474,929 | $19.3M | 2.78% |
| 12 | AEROVATE THERAPEUTICS INC | 008064107 | 621,712 | $12.5M | 1.80% |
| 13 | JASPER THERAPEUTICS INC | JSPRW | 6,382,500 | $11.6M | 1.66% |
| 14 | TRAVERE THERAPEUTICS INC | TVTX | 495,000 | $11.1M | 1.60% |
| 15 | ALPINE IMMUNE SCIENCES INC | 02083G100 | 1,202,000 | $9.3M | 1.34% |
| 16 | 4D MOLECULAR THERAPEUTICS IN | FDMT | 499,996 | $8.6M | 1.24% |
| 17 | ITEOS THERAPEUTICS INC | 46565G104 | 596,000 | $8.1M | 1.17% |
| 18 | DYNE THERAPEUTICS INC | DYN | 692,945 | $8.0M | 1.15% |
| 19 | XILIO THERAPEUTICS INC | XLO | 2,425,000 | $7.7M | 1.11% |
| 20 | VIKING THERAPEUTICS INC | VKTX | 375,000 | $6.2M | 0.90% |
| 21 | VERA THERAPEUTICS INC | VERA | 795,000 | $6.2M | 0.89% |
| 22 | 89BIO INC | 282559103 | 400,000 | $6.1M | 0.88% |
| 23 | AVIDITY BIOSCIENCES INC | 05370A108 | 382,000 | $5.9M | 0.84% |
| 24 | INTRA-CELLULAR THERAPIES INC | 46116X101 | 94,700 | $5.1M | 0.74% |
| 25 | GERON CORP | GERN | 2,278,000 | $4.9M | 0.71% |
| 26 | ACLARIS THERAPEUTICS INC | ACRS | 577,000 | $4.7M | 0.67% |
| 27 | ANNEXON INC | ANNX | 1,190,000 | $4.6M | 0.66% |
| 28 | GLYCOMIMETICS INC | 38000Q102 | 3,000,000 | $3.8M | 0.54% |
| 29 | RENEO PHARMACEUTICALS INC | 75974E103 | 420,000 | $2.5M | 0.36% |
| 30 | GOSSAMER BIO INC | GOSS | 1,958,069 | $2.5M | 0.35% |
| 31 | STRUCTURE THERAPEUTICS INC | GPCR | 93,692 | $2.2M | 0.32% |
| 32 | BRIDGEBIO PHARMA INC | BBIO | 100,000 | $1.7M | 0.24% |
| 33 | STOKE THERAPEUTICS INC | STOK | 185,669 | $1.5M | 0.22% |
| 34 | CENTESSA PHARMACEUTICALS PLC | CNTA | 396,000 | $1.5M | 0.22% |
| 35 | VECTIVBIO HLDG AG | H9060V101 | 35,259 | $300,054 | 0.04% |
| 36 | PIERIS PHARMACEUTICALS INC | 720795103 | 301,490 | $294,254 | 0.04% |